NPI Details
PASTEUR INC is a clinical medical laboratory in Van Nuys, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PASTEUR INC NPI is 1043244726. The provider is registered as an organization entity type.
The provider .
The provider's business location address is:
6700 VALJEAN AVE
VAN NUYS, CA
ZIP 91406-818
Phone: (310) 873-6380
Fax: (310) 873-6780
The provider's authorized official is Meirah Lev .
The authorized official title is Coo and has the following contact phone number (310) 873-6380.
The CLIA number assigned to this NPI record is 05D0930353 - independent with a certificate type of Certificate of Compliance.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
- Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
- Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
- Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
- Fee covid-19 vac 14 res (HCPCS:0134A)
- Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
- Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
- Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
- Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
- Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
- Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
The enumeration date for this NPI number is 7/10/2006 and was last updated on 7/10/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | 05D0930353 | CALIFORNIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 3745930 | MEDICAID | CALIFORNIA | |
| 2 | 0816838 | MEDICAID | CALIFORNIA | |
